Cost-benefit analysis, Cost-effectiveness analysis, Dashboard design, Data Visualization
Recent evidence has encouraged low- and middle-income countries (LMIC) to consider transitioning from long-standing iron and folic acid supplementation (IFAS) to multiple micronutrient supplementation (MMS) during pregnancy. However, global guidance to facilitate this transition is limited.
To aid countries’ decision-making, Nutrition International, in partnership with Limestone Analytics, developed the MMS Cost-Benefit Tool. The tool applies a rigorous methodology to calculate the incremental benefits and costs of transitioning from IFAS to MMS in LMICs (Kashi et al., 2018). More information about the original work with Nutrition International that informed the development of this tool can be found here. In this context, the term “transition” refers to substituting IFAS with MMS for pregnancy care in a government’s antenatal service package.
Figure: MMS Cost-Benefit Tool Interface
Across the 12 countries in the tool, transitioning MMS has consistently found to yield positive infant health outcomes and found to be very cost-effective.
Since launching the tool, a number of country offices worldwide have used the MMS cost-benefit tool to evaluate whether transitioning in their context is cost-effective. The tool can be accessed here.
Clients / Partners
Development and piloting of the IFAS or MMS Cost-benefit tool